If you do business development for a CRO, a lab or reagent supplier, or a patient recruitment firm, you already know the timing trick: the moment a sponsor posts a new trial, especially an early Phase 1, is the moment their vendor budget is still up for grabs. A week later the CRO shortlist is already locked in and you're too late.
The data that tells you this is happening is public. ClinicalTrials.gov runs a free API (no key, no login) that anyone can query by sponsor, condition, phase, or status, and it updates the same day a trial gets posted. The problem isn't access, it's that almost nobody on a BD or competitive intelligence team is going to hand-write API queries and re-run them every morning. So the fallback is either a manual check nobody keeps up with, or a subscription to an enterprise competitive-intelligence platform priced for teams that need a lot more than "tell me when this sponsor posts a trial."
That gap is exactly what clinical-trial-tracker fills. Give it a sponsor name, a condition, a phase, or any combination, and it returns every trial matching that filter, most recent first: sponsor, phase, condition, site countries, and the first-posted date. Point it at "terminated" status instead of "new" and the same tool becomes a risk signal instead of a buying signal, a competitor's trial getting pulled is worth knowing about too.
You can try a live search right now with no Apify account needed, or run it directly on Apify for your own recurring checks.
It's billed per search, not per trial returned, so checking a shortlist of 15 sponsors every morning costs the same whether each one has 1 new trial or none. No proxy, no scraping, no login, it reads the same public API ClinicalTrials.gov's own site is built on.
See it alongside the rest of the early-signal and risk-monitoring actors in the portfolio, including Insider Trading Alert for executive buy/sell signals and Product Recall Alert for FDA drug/food/device recalls.